자궁내막증 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Endometriosis Trends and Forecast

The future of the global endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets. The global endometriosis market is expected to reach an estimated $3.1 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

A more than 150-page report is developed to help in your business decisions.

Endometriosis by Segment

The study includes a forecast for the global endometriosis by type, distribution channel, treatment, end use industry, and region.

Endometriosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Superficial Peritoneal Lesion
• Endometriomas
• Others

Endometriosis Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Endometriosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Oral Contraceptives
• Gonadotropin-Releasing Hormone (GnRH) Medicines
• Others

Endometriosis Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Homecare
• Speciality Centers
• Others

Endometriosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Endometriosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endometriosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endometriosis companies profiled in this report include-

• Consilient Health
• Sun Pharmaceutical
• Sanofi
• Astrazeneca
• Serum Institute Of India
• Pfizer
• Teva Pharmaceutical Industries
• Glaxosmithkline
• Merck
• Abbott Laboratories

Endometriosis Market Insights

Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Hospitals will remain the largest segment due to the increase in the number of hospital pharmacies and growing patient preference for hospitals due to their high-quality services and facilites.

APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Features of the Global Endometriosis Market

Market Size Estimates: Endometriosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endometriosis market by various segments, such as by type, distribution channel, treatment, end use industry and region in terms of($B).

Regional Analysis: Endometriosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, treatments, end use industries, and region.s for the endometriosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endometriosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the endometriosis market size?

Answer: The global endometriosis market is expected to reach an estimated $3.1 billion by 2030.

Q.2. What is the growth forecast for endometriosis market?

Answer: The global endometriosis market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the endometriosis market?

Answer: The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

Q.4. What are the major segments for endometriosis market?

Answer: The future of the endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets.

Q.5. Who are the key Endometriosis Market companies?

Answer: Some of the key endometriosis companies are as follows:

• Consilient Health
• Sun Pharmaceutical
• Sanofi
• AstraZeneca
• Serum Institute of India
• Pfizer
• Teva Pharmaceutical Industries
• GlaxoSmithKline
• Merck
• Abbott Laboratories

Q.6. Which endometriosis market segment will be the largest in future?

Answer: Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Q.7. In endometriosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the endometriosis market by type (superficial peritoneal lesion, endometriomas, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), treatment (oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines, and others), end use industry (hospitals, homecare, speciality centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Endometriosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Endometriosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Endometriosis Market by Type
  • 3.3.1: Superficial Peritoneal Lesion
  • 3.3.2: Endometriomas
  • 3.3.3: Others
• 3.4: Global Endometriosis Market by Distribution channel
  • 3.4.1: Hospital Pharmacy
  • 3.4.2: Online Pharmacy
  • 3.4.3: Retail Pharmacy
• 3.5: Global Endometriosis Market by Treatment
  • 3.5.1: Oral Contraceptives
  • 3.5.2: Gonadotropin-Releasing Hormone (GnRH) Medicines
  • 3.5.3: Others
• 3.6: Global Endometriosis Market by End Use Industry
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Speciality Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Endometriosis Market by Region
• 4.2: North American Endometriosis Market
  • 4.2.2: North American Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
• 4.3: European Endometriosis Market
  • 4.3.1: European Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
  • 4.3.2: European Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
• 4.4: APAC Endometriosis Market
  • 4.4.1: APAC Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
  • 4.4.2: APAC Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
• 4.5: ROW Endometriosis Market
  • 4.5.1: ROW Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
  • 4.5.2: ROW Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Endometriosis Market by Type
  • 6.1.2: Growth Opportunities for the Global Endometriosis Market by Distribution channel
  • 6.1.3: Growth Opportunities for the Global Endometriosis Market by Treatment
  • 6.1.4: Growth Opportunities for the Global Endometriosis Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Endometriosis Market by Region
• 6.2: Emerging Trends in the Global Endometriosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Endometriosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endometriosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Consilient Health
• 7.2: Sun Pharmaceutical
• 7.3: Sanofi
• 7.4: AstraZeneca
• 7.5: Serum Institute of India
• 7.6: Pfizer
• 7.7: Teva Pharmaceutical Industries
• 7.8: GlaxoSmithKline
• 7.9: Merck
• 7.10: Abbott Laboratories